News

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's record demand for Dupixent, state of drug innovation in Europe, company outlook, and more. More for You.
Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, 2025 outlook, drug pipeline, the company's dividend and buyback decision, his thoughts on the ...
Sanofi CEO Paul Hudson speaks during the Competing In The Global Marketplace: Strategies for Growth panel, at the Fortune Global Forum on Nov. 11, 2024 in New York City.
Sanofi has doubled down on its partnership with Adagene, investing $25 million in the biotech, taking up its option on a ...
Sanofi Chief Executive Paul Hudson said the Blueprint acquisition had been in the making for a long time and that work started long before last week’s update. “We’ve had a bit of a bumpy ...
The revamp of French drugmaker Sanofi under new chief executive Paul Hudson has filtered up to top management, with four senior figures leaving the company. The move comes shortly after Hudson ...
Paul Hudson, CEO of Sanofi, works in a volatile business. The pharma sector has been very profitable for many decades, and its weight in the economy has grown steadily.
MORRISTOWN − Gov. Phil Murphy joined Sanofi CEO Paul Hudson on May 22 for the formal grand-opening of French pharmaceutical giant Sanofi's new U.S. flagship office , the home for about 2,000 ...
Hudson says many CEOs are scared of AI, comparing it to The Terminator’s John Connor traveling back in time to stop the rise of the machines. Sanofi CEO Paul Hudson takes inspiration from ...